Physician

Colin Andrew Hardin, M.D.

According to 2025 Medicare claims, Colin Hardin, M.D. (NPI: 1639459860) practices medical oncology in the Muskegon-Norton Shores, MI market, with the plurality of this provider's patient population coming from Muskegon, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 49444-9739. Hardin is affiliated with the Trinity Health Integrated Care (ACO ID: A3454) and West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Hardin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 413 traditional Medicare patients, billed 89,565 HCPCS/CPT codes, and received $1,334,961 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,103 prescription claims across 236 beneficiaries totaling $6,864,011 in drug costs, led by Revlimid (Lenalidomide). 2019 DME data shows 38 claims. Open Payments data shows 106 records totaling $607,515. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $14,375 to $1,334,961. Similarly, Part D prescription costs have moved sharply higher in recent years, from $35,216 to $6,864,011. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.